Masana L - Search Results

1

Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.

González-Lleó AM, Sánchez-Hernández RM, Plana N, Ibarretxe D, Rehues P, Ribalta J, Llop D, Wägner AM, Masana L, Boronat M. González-Lleó AM, et al. Among authors: masana l. Cardiovasc Diabetol. 2024 Jan 3;23(1):4. doi: 10.1186/s12933-023-02077-y. Cardiovasc Diabetol. 2024. PMID: 38172901 Free PMC article.

2

Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages.

Vallvé JC, Uliaque K, Girona J, Cabré A, Ribalta J, Heras M, Masana L. Vallvé JC, et al. Among authors: masana l. Atherosclerosis. 2002 Sep;164(1):45-56. doi: 10.1016/s0021-9150(02)00046-1. Atherosclerosis. 2002. PMID: 12119192

3

Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia.

Ribalta J, Figuera L, Fernández-Ballart J, Vilella E, Castro Cabezas M, Masana L, Joven J. Ribalta J, et al. Among authors: masana l. Clin Chem. 2002 Sep;48(9):1597-600. Clin Chem. 2002. PMID: 12194944 No abstract available.

4

Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease.

Ribalta J, Vallvé JC, Girona J, Masana L. Ribalta J, et al. Among authors: masana l. Curr Opin Clin Nutr Metab Care. 2003 Mar;6(2):177-87. doi: 10.1097/00075197-200303000-00006. Curr Opin Clin Nutr Metab Care. 2003. PMID: 12589187 Review.

5

Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II).

Salazar J, Ferré R, Vallvé JC, Pocoví M, Cabezas MC, Masana L, Ribalta J. Salazar J, et al. Among authors: masana l. Mol Cell Probes. 2003 Feb;17(1):21-3. doi: 10.1016/s0890-8508(02)00110-x. Mol Cell Probes. 2003. PMID: 12628590

6

The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects.

Masana L, Ribalta J, Salazar J, Fernández-Ballart J, Joven J, Cabezas MC. Masana L, et al. Clin Chem Lab Med. 2003 Apr;41(4):517-21. doi: 10.1515/CCLM.2003.078. Clin Chem Lab Med. 2003. PMID: 12747596

7

Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.

Masana L, Villoria J, Sust M, Ros E, Plana N, Pérez-Jiménez F, Franco M, Oliván JJ, Pintó X, Videla S. Masana L, et al. Eur J Pharmacol. 2004 Aug 2;496(1-3):205-12. doi: 10.1016/j.ejphar.2004.05.041. Eur J Pharmacol. 2004. PMID: 15288592 Clinical Trial.

8

[Objective-oriented planification in the treatment of hypercholesterolemia].

Masana L, Plana N. Masana L, et al. Med Clin (Barc). 2005 Jan 29;124(3):108-10. doi: 10.1157/13070853. Med Clin (Barc). 2005. PMID: 15710098 Spanish. No abstract available.

9

Additive effects of the PPARgamma, APOE, and FABP-2 genes in increasing daylong triglycerides of normolipidemic women to concentrations comparable to those in men.

Ribalta J, Halkes CJ, Salazar J, Masana L, Cabezas MC. Ribalta J, et al. Among authors: masana l. Clin Chem. 2005 May;51(5):864-71. doi: 10.1373/clinchem.2004.044347. Epub 2005 Mar 11. Clin Chem. 2005. PMID: 15764642

10

Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variation.

Guardiola M, Ferré R, Salazar J, Alonso-Villaverde C, Coll B, Parra S, Masana L, Ribalta J. Guardiola M, et al. Among authors: masana l. Clin Chem. 2006 Oct;52(10):1914-9. doi: 10.1373/clinchem.2006.069583. Epub 2006 Aug 3. Clin Chem. 2006. PMID: 16887900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page